ENTITY

Orum Therapeutics (475830 KS)

10
Analysis
Health Care • South Korea
Orum Therapeutics, Inc. operates as a clinical stage biotech company. The Company develops cell-penetrating antibodies, biomedical therapy applications, and pharmaceuticals for cancer and immune diseases. Orum Therapeutics serves clients worldwide.
more
bearish•Hanwha Engine
•28 Feb 2025 18:52

End of Mandatory Lock-Up Periods for 43 Companies in Korea in March 2025

This insight provide a list of 43 stocks (2 KOSPI and 41 KOSDAQ) with end of mandatory lock-up periods for certain shares in March 2025.

Logo
683 Views
Share
•03 Jan 2025 20:08

Orum Therapeutics Lowers IPO Price Range

Orum Therapeutics (475830 KS) has lowered its IPO price range to 24,000 won to 30,000 won. The expected market cap of the IPO is between 531...

Logo
786 Views
Share
•24 Oct 2024 05:55

Orum Therapeutics IPO Valuation Analysis

Our base case target price for Orum Therapeutics is 35,170 won per share, which is within the IPO price range of 30,000 won to 36,000 won per share.

Logo
502 Views
Share
•08 Oct 2024 21:22

Orum Therapeutics IPO Preview

Orum Therapeutics is getting ready to complete its IPO in KOSDAQ in November 2024.The expected market cap after IPO is from 648 billion won to 778...

Logo
750 Views
Share
x